The FDA has now cleared four Alzheimer’s blood tests. A physician explains what each one measures, how accurate it is, who ...

Cancer isn't the leading cause of death in the United States; heart disease ranks first in that regard. But it's cancer that ...

Mercy BioAnalytics, Inc. ("Mercy"), a commercial-stage company developing blood-based tests for early cancer detection, today ...

Billy Evans’ startup Haemanthus says it’s not “Theranos 2.0.” But reporting by Forbes on cofounders Lauren Friedman Stat, a ...

Roche and Genentech will present Alzheimer’s drug and blood-diagnostic research at CTAD 2026, including a new Phase II trial ...

Blood tests that can detect signs of several cancers from a single sample will be offered to NHS patients in a world-first ...

Hemochromatosis is a disorder that causes your body to absorb too much iron. Blood tests that measure iron levels in your blood and liver can help diagnose the condition. The medical disorder ...

More than 20,000 patients aged 45 or over with abdominal symptoms will take part in the trial, which runs until October 2031.

The clue isn’t a brain scan or a new biomarker, but a number buried in a routine check-up most adults have already had.

A complete blood count (CBC) is a common test to diagnose anemia by measuring red blood cell count, hemoglobin, and hematocrit levels. Iron deficiency is a common cause of anemia, and doctors may ...

Natera is in a similar boat, posting losses of 42 cents per share, vs. expectations for a 29-cent loss. The company also ...

The aim is to detect hard-to-diagnose abdominal cancers, including liver, ovarian and pancreatic cancer, much sooner.